Documents

Discussions Technicals Forecast Seasonals Options Bonds

Vaxart, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Vaxart, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

H.C. Wainwright 27th Annual Global Investment Conference

Sep 08, 2025

Transcript

Q2 2025

Aug 13, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

Study Result

Jun 11, 2025

Press release

Q1 2025

May 13, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

The Citizens JMP Life Sciences Conference 2025

May 07, 2025

Slides

2024

Q4 2024

Mar 20, 2025

Transcript

Annual report10-K

Earnings release8-K

Q3 2024

Nov 13, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 08, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 13, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 14, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 02, 2023

Quarterly report10-Q

Slides

Earnings release8-K

Investor Presentation

Nov 02, 2023

Slides

Study Result

Sep 06, 2023

Press release

Slides

Q2 2023

Aug 03, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 04, 2023

Quarterly report10-Q

Earnings release8-K

Study Update

Mar 28, 2023

Slides

2022

Q4 2022

Mar 15, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 08, 2022

Quarterly report10-Q

Earnings release8-K

Study Result

Sep 01, 2022

Press release

Q2 2022

Aug 08, 2022

Quarterly report10-Q

Earnings release8-K

2021

Q4 2021

Feb 24, 2022

Annual report10-K

2020

Q4 2020

Feb 25, 2021

Annual report10-K

2019

Q4 2019

Mar 19, 2020

Annual report10-K

2018

Q4 2018

Feb 06, 2019

Annual report10-K

2017

Q4 2017

Sep 01, 2017

Annual report10-K

2016

Q4 2016

Sep 13, 2016

Annual report10-K

2015

Q4 2015

Sep 11, 2015

Annual report10-K